http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112216384-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bbdac88c2bd304b523b4ea0ea461bea |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-201 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20 |
filingDate | 2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff9d5bcf6cda283c8d8e13dc8fbace56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44a1830b21bac63145a1b9ea293a0d6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bcb4e1516b69dc44d6da608ba3f0f9b |
publicationDate | 2021-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112216384-A |
titleOfInvention | Diabetic nephropathy risk assessment system |
abstract | The invention discloses a diabetic nephropathy risk assessment system, which relates to the field of medical instruments, and comprises: the limiting device is used for determining whether to carry out diabetic nephropathy risk assessment limitation on the patient according to the medical history and the medical course of the patient; and the evaluation device is used for performing low-risk, medium-risk and high-risk evaluation on the diabetic nephropathy by using the diabetes related indexes and the indexes reflecting the damage of the kidney function if the diabetic nephropathy risk evaluation limit on the patient is determined not to be performed. |
priorityDate | 2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.